DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. (Q45765790)

15 December 2017

title

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. (English)

1 reference

15 December 2017

0 references

Bourne N

1

1 reference

15 December 2017

Milligan GN

2

1 reference

15 December 2017

Schleiss MR

3

1 reference

15 December 2017

Bernstein DI

4

1 reference

15 December 2017

Stanberry LR

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

14

1 reference

15 December 2017

issue

13

1 reference

15 December 2017

page(s)

1230-1234

1 reference

15 December 2017

Direct gene transfer into mouse muscle in vivo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Immunization with plasmid DNA using a pneumatic gun.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Genetic vaccination against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Translational control of human cytomegalovirus gp48 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

The common mucosal immune system and current strategies for induction of immune responses in external secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Native HSV Glycoprotein D Subunit Vaccine: Analysis ofin VitroT-Cell Activation and Antigen Presentation*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

DNA vaccination against persistent viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Genital herpesvirus hominis infection in mice. I. Development of an experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Acyclovir treatment of experimental genital herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Pathogenesis of Herpes Simplex Virus in Congenitally Athymic Mice: the Relative Roles of Cell-mediated and Humoral Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Pathogenesis of Herpes Simplex Virus in B Cell-suppressed Mice: the Relative Roles of Cell-mediated and Humoral Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900027-8

7 January 2021

10.1016/S0264-410X(96)00027-8

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

8961510

1 reference

15 December 2017